Td Private Client Wealth LLC Amgen Inc Transaction History

Td Private Client Wealth LLC

$4.07 Trillion
Q2 2025

A detailed history of Td Private Client Wealth LLC transactions in Amgen Inc stock. As of the latest transaction made, Td Private Client Wealth LLC holds 25,608 shares of AMGN stock, worth $7.85 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

25,608

Previous 24,113 6.2%

Holding current value

$7.85 Million

Previous $7.51 Billion 4.82%

% of portfolio

0.18%

Previous 0.21%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Jul 15, 2025	BUY	$262.28 - $309.85 $392,108 - $463,225	1,495 Added 6.2%	25,608 $7.15 Billion
Q1 2025 Apr 29, 2025	BUY	$258.59 - $327.36 $381,420 - $482,856	1,475 Added 6.52%	24,113 $7.51 Billion
Q4 2024 Feb 11, 2025	BUY	$258.78 - $328.31 $257,744 - $326,996	996 Added 4.6%	22,638 $5.9 Billion
Q3 2024 Nov 18, 2024	SELL	$309.38 - $337.38 $732,302 - $798,578	-2,367 Reduced 9.86%	21,642 $6.97 Billion
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $6.31 Million - $7.67 Million	24,009 New	24,009 $7.5 Billion
Q1 2024 Aug 16, 2024	SELL	$268.87 - $324.56 $589,900 - $712,084	-2,194 Reduced 9.44%	21,057 $5.99 Billion
Q4 2023 Aug 16, 2024	SELL	$255.7 - $288.46 $2.43 Million - $2.75 Million	-9,519 Reduced 29.05%	23,251 $6.7 Billion
Q3 2023 Aug 16, 2024	SELL	$218.65 - $271.46 $218,212 - $270,917	-998 Reduced 2.96%	32,770 $8.82 Billion
Q2 2023 Aug 16, 2024	BUY	$214.27 - $253.37 $1.61 Million - $1.9 Million	7,492 Added 28.51%	33,768 $7.5 Billion
Q1 2023 Aug 16, 2024	BUY	$225.79 - $275.2 $1.4 Million - $1.71 Million	6,202 Added 30.9%	26,276 $6.35 Billion
Q4 2022 Aug 16, 2024	SELL	$229.03 - $291.01 $2.16 Million - $2.74 Million	-9,420 Reduced 31.94%	20,074 $5.28 Billion
Q3 2022 Aug 16, 2024	BUY	$224.46 - $253.15 $1.01 Million - $1.14 Million	4,488 Added 17.95%	29,494 $6.65 Billion
Q2 2022 Aug 16, 2024	SELL	$230.71 - $256.74 $58,831 - $65,468	-255 Reduced 1.01%	25,006 $6.09 Billion
Q1 2022 Aug 16, 2024	BUY	$219.27 - $242.57 $1.79 Million - $1.98 Million	8,171 Added 47.81%	25,261 $6.11 Billion
Q4 2021 Aug 16, 2024	BUY	$198.88 - $227.6 $446,286 - $510,734	2,244 Added 15.12%	17,090 $3.84 Billion
Q3 2021 Aug 16, 2024	SELL	$212.27 - $248.7 $1.95 Million - $2.28 Million	-9,163 Reduced 38.16%	14,846 $3.16 Billion
Q2 2021 Aug 16, 2024	SELL	$233.58 - $259.14 $443,802 - $492,366	-1,900 Reduced 15.28%	10,534 $2.57 Billion
Q1 2021 Aug 16, 2024	BUY	$221.91 - $258.6 $35,283 - $41,117	159 Added 1.3%	12,434 $3.09 Billion
Q4 2020 Aug 16, 2024	BUY	$216.38 - $257.67 $254,895 - $303,535	1,178 Added 10.62%	12,275 $2.82 Billion
Q3 2020 Aug 16, 2024	SELL	$234.65 - $260.95 $215,643 - $239,813	-919 Reduced 7.65%	11,097 $2.82 Billion
Q2 2020 Aug 16, 2024	BUY	$197.81 - $242.74 $247,855 - $304,153	1,253 Added 11.64%	12,016 $2.83 Billion
Q1 2020 Aug 16, 2024	SELL	$182.24 - $241.7 $350,629 - $465,030	-1,924 Reduced 15.17%	10,763 $2.18 Billion
Q4 2019 Aug 16, 2024	SELL	$189.21 - $243.2 $2.14 Million - $2.75 Million	-11,322 Reduced 47.16%	12,687 $3.06 Billion

Others Institutions Holding AMGN

# of Institutions

3,285

Shares Held

426M

Call Options Held

8.07M

Put Options Held

7.7M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $164B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Private Client Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Td Private Client Wealth LLC with notifications on news.

Account

Td Private Client Wealth LLC Amgen Inc Transaction History